Dolby Laboratories Yönetim

Yönetim kriter kontrolleri 3/4

Dolby Laboratories CEO'su Kevin Yeaman, Mar2009 tarihinde atandı, in görev süresi 15.67 yıldır. in toplam yıllık tazminatı $ 9.50M olup, şirket hissesi ve opsiyonları dahil olmak üzere 9.8% maaş ve 90.2% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.088% ine doğrudan sahiptir ve bu hisseler € 6.48M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 8.1 yıl ve 11.8 yıldır.

Anahtar bilgiler

Kevin Yeaman

İcra Kurulu Başkanı

US$9.5m

Toplam tazminat

CEO maaş yüzdesi	9.8%
CEO görev süresi	15.7yrs
CEO sahipliği	0.09%
Yönetim ortalama görev süresi	8.1yrs
Yönetim Kurulu ortalama görev süresi	11.8yrs

Son yönetim güncellemeleri

Recent updates

CEO Tazminat Analizi

Kevin Yeaman'un ücretlendirmesi Dolby Laboratories'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Sep 27 2024	n/a	n/a	US$262m
Jun 28 2024	n/a	n/a	US$212m
Mar 29 2024	n/a	n/a	US$190m
Dec 29 2023	n/a	n/a	US$188m
Sep 29 2023	US$10m	US$929k	US$201m
Jun 30 2023	n/a	n/a	US$219m
Mar 31 2023	n/a	n/a	US$242m
Dec 30 2022	n/a	n/a	US$183m
Sep 30 2022	US$9m	US$919k	US$184m
Jul 01 2022	n/a	n/a	US$201m
Apr 01 2022	n/a	n/a	US$216m
Dec 31 2021	n/a	n/a	US$255m
Sep 24 2021	US$10m	US$872k	US$310m
Jun 25 2021	n/a	n/a	US$293m
Mar 26 2021	n/a	n/a	US$306m
Dec 25 2020	n/a	n/a	US$318m
Sep 25 2020	US$8m	US$847k	US$231m
Jun 26 2020	n/a	n/a	US$248m
Mar 27 2020	n/a	n/a	US$221m
Dec 27 2019	n/a	n/a	US$206m
Sep 27 2019	US$7m	US$818k	US$255m
Jun 28 2019	n/a	n/a	US$238m
Mar 29 2019	n/a	n/a	US$201m
Dec 28 2018	n/a	n/a	US$193m
Sep 28 2018	US$8m	US$783k	US$42m

Tazminat ve Piyasa: Kevin 'nin toplam tazminatı ($USD 9.50M ), German pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 3.59M ).

Tazminat ve Kazançlar: Kevin 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.

CEO

Kevin Yeaman (58 yo)

15.7yrs

Görev süresi

US$9,504,201

Tazminat

Mr. Kevin J. Yeaman has been the Chief Executive Officer and President of Dolby Laboratories, Inc. since March 28, 2009 and serves as its Director since March 28, 2009. Mr. Yeaman served as the Chief Finan...

Liderlik Ekibi

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Kevin Yeaman	President	15.7yrs	US$9.50m	0.088% € 6.5m
Robert Park	Senior VP & CFO	3.1yrs	US$3.29m	0.019% € 1.4m
Andy Sherman	Executive VP	13.8yrs	US$3.51m	0.018% € 1.3m
Todd Pendleton	Senior VP & Chief Marketing Officer	6.3yrs	US$3.19m	Veri yok
John Couling	Senior Vice President of Entertainment	8.1yrs	US$3.90m	0.067% € 4.9m
Ryan Nicholson	VP, Corporate Controller & Chief Accounting Officer	9.3yrs	Veri yok	0.010% € 735.3k
Craig Todd	CTO & Senior VP	no data	Veri yok	Veri yok
Edwin Marin	Senior VP & Chief Information Officer	no data	Veri yok	Veri yok
Peter Goldmacher	Vice President of Investor Relations	no data	Veri yok	Veri yok
Linda Rogers	Senior VP & Chief People Officer	7.8yrs	Veri yok	Veri yok
Ioan Allen	Senior Vice President	no data	Veri yok	Veri yok
Giles Baker	Senior Vice President of Cloud Media Solutions	8.1yrs	US$3.36m	Veri yok

8.1yrs

Ortalama Görev Süresi

52.5yo

Ortalama Yaş

Deneyimli Yönetim: FUO 'un yönetim ekibi deneyimli ve deneyimlidir ( 8.1 yıldır).

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Kevin Yeaman	President	15.7yrs	US$9.50m	0.088% € 6.5m
Peter Gotcher	Independent Chairman	21.4yrs	US$415.48k	0.043% € 3.1m
Avadis Tevanian	Independent Director	15.8yrs	US$367.48k	0.059% € 4.4m
Simon Segars	Independent Director	9.8yrs	US$345.48k	0.039% € 2.9m
Tony Prophet	Independent Director	2.9yrs	US$338.94k	0.0066% € 488.7k
Anjali Sud	Independent Director	5.5yrs	US$335.48k	0.0064% € 470.2k
David Dolby	Director	13.8yrs	US$330.48k	0.087% € 6.4m
Emily Rollins	Independent Director	3.8yrs	US$355.48k	0.0048% € 351.4k

11.8yrs

Ortalama Görev Süresi

58yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: FUO 'in yönetim kurulu deneyimli ve tecrübelidir (ortalama görev süresi 11.8 yıldır).

Dolby Laboratories Yönetim

Yönetim kriter kontrolleri 3/4

Anahtar bilgiler

Son yönetim güncellemeleri

Senior VP & Chief Marketing Officer recently sold €933k worth of stock

Insufficient new directors

Dolby Laboratories, Inc. Announces Committee Changes

Dolby Laboratories, Inc., Annual General Meeting, Feb 06, 2024

Senior VP & Chief Marketing Officer recently sold €799k worth of stock

Independent Director recently sold €198k worth of stock

Recent updates

Dolby Laboratories, Inc. Provides Earnings Guidance for the First Quarter and Full Year of Fiscal 2025

Dolby Laboratories, Inc. to Report Q4, 2024 Results on Nov 19, 2024

Dolby Unveils New, Live Streaming Offering for the Sport and Entertainment Industries At IBC 2024

Third quarter dividend of US$0.30 announced

Third quarter 2024 earnings released: EPS: US$0.40 (vs US$0.17 in 3Q 2023)

Dolby Laboratories, Inc. Announces Cash Dividend on Class A and Class B Common Stock, Payable on August 27, 2024

Now 22% undervalued after recent price drop

Dolby Laboratories, Inc. (NYSE:DLB) acquired THEOplayer.

Dolby Laboratories, Inc. to Report Q3, 2024 Results on Aug 07, 2024

Dolby Laboratories, Inc. (NYSE:DLB) entered into a definitive agreement to acquire Ge Trademark Licensing, Inc. from General Electric Company (NYSE:GE) for approximately $430 million.

Second quarter dividend of US$0.30 announced

Second quarter 2024 earnings released: EPS: US$1.02 (vs US$1.00 in 2Q 2023)

Dolby Laboratories, Inc. Announces Cash Dividend on Class A and Class B Common Stock, Payable on May 22, 2024

Dolby Laboratories, Inc. to Report Q2, 2024 Results on May 02, 2024

Senior VP & Chief Marketing Officer recently sold €933k worth of stock

Insufficient new directors

Dolby Laboratories, Inc. Announces Committee Changes

First quarter dividend of US$0.30 announced

First quarter 2024 earnings released: EPS: US$0.70 (vs US$0.83 in 1Q 2023)

Dolby Laboratories, Inc. Provides Earnings Guidance for the Second Quarter and Full Year of 2024

Dolby Laboratories, Inc. to Report Q1, 2024 Results on Feb 01, 2024

Dolby Laboratories, Inc., Annual General Meeting, Feb 06, 2024

Full year 2023 earnings released: EPS: US$2.10 (vs US$1.84 in FY 2022)

Dolby Laboratories, Inc. Provides Earnings Guidance for the First Quarter and Full Year of Fiscal 2024

Dolby Laboratories, Inc. to Report Fiscal Year 2023 Results on Nov 16, 2023

Dolby Laboratories, Inc. Unveils New Dolby Atmos Innovation Coming to TCL TVS Ahead of IFA 2023

Dolby Laboratories, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year of Fiscal 2023

Third quarter 2023 earnings released: EPS: US$0.17 (vs US$0.40 in 3Q 2022)

Dolby Laboratories, Inc. to Report Q3, 2023 Results on Aug 03, 2023

Second quarter 2023 earnings released: EPS: US$1.00 (vs US$0.36 in 2Q 2022)

Dolby Laboratories, Inc. Announces Cash Dividend, Payable on May 23, 2023

Now 21% undervalued

Senior VP & Chief Marketing Officer recently sold €799k worth of stock

Independent Director recently sold €198k worth of stock

Independent Chairman recently sold €497k worth of stock

First quarter 2023 earnings released: EPS: US$0.83 (vs US$0.79 in 1Q 2022)

Dolby Laboratories, Inc. Announces Cash Dividend on Class A and Class B Common Stock, Payable on February 22, 2023

Dolby Laboratories, Inc. to Report Q1, 2023 Results on Feb 02, 2023

Dolby Laboratories, Inc., Annual General Meeting, Feb 07, 2023

Upcoming dividend of US$0.27 per share

Full year 2022 earnings released: EPS: US$1.84 (vs US$3.07 in FY 2021)

Dolby Laboratories, Inc. Provides Revenue Guidance for the Fiscal 2023

Dolby Laboratories, Inc. to Report Q4, 2022 Results on Nov 17, 2022

Upcoming dividend of US$0.25 per share

Third quarter 2022 earnings released: EPS: US$0.40 (vs US$0.54 in 3Q 2021)

Dolby Laboratories, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year of Fiscal 2022

Dolby Laboratories, Inc. to Report Q3, 2022 Results on Aug 09, 2022

Insider recently sold €105k worth of stock

Second quarter 2022 earnings released: EPS: US$0.36 (vs US$0.75 in 2Q 2021)

Dolby Laboratories, Inc. Provides Earnings Guidance for the Third Quarter of Fiscal 2022 and Full Year Fiscal 2022

Dolby Laboratories, Inc. Announces Executive Changes

Dolby Laboratories, Inc. to Report Q2, 2022 Results on May 05, 2022

Dolby Laboratories, Inc. Announces General Availability of Dolby.io Transcode API

Upcoming dividend of US$0.25 per share

Dolby Laboratories, Inc. (NYSE:DLB) acquired Millicast, Inc. for $39 million.

Dolby Announces A Cash Dividend Payable on February 23, 2022

First quarter 2022 earnings: EPS in line with expectations, revenues disappoint

Full year 2021 earnings released: EPS US$3.07 (vs US$2.30 in FY 2020)

Insider recently sold €145k worth of stock

Senior VP & Chief Marketing Officer recently sold €232k worth of stock

Upcoming dividend of US$0.22 per share

Third quarter 2021 earnings released: EPS US$0.54 (vs US$0.67 in 3Q 2020)

Dolby Laboratories, Inc.(NYSE:DLB) dropped from Russell 3000 Growth Index

Dolby Laboratories Reaffirms Revenue Guidance for the Year 2021

Second quarter 2021 earnings released: EPS US$0.75 (vs US$0.88 in 2Q 2020)

Dolby Laboratories, Inc. Provides Earnings Guidance for the Third Quarter and Second Half of 2021

New 90-day high: €81.50

Dolby Laboratories, Inc. Appoints Emily Rollins to the Board

Senior VP & Chief Marketing Officer recently sold €179k worth of stock